Oral immunotherapy may induce T cell anergy

Area of Science:

• Immunology
• Allergy and Asthma Research
• Clinical Therapeutics

Background:

• T cell anergy induction is a complex immunotherapy approach.
• The diversity of T cell epitopes limits practical application.
• Oral antigen administration offers a potentially simpler therapeutic route.

Purpose of the Study:

• To evaluate the efficacy of oral immunotherapy (OIT) with Dermatophagoides farinae mite extract in adult asthmatic patients.
• To assess the impact of OIT on clinical symptoms, lung function, and inflammatory markers.
• To investigate the potential of OIT to induce T cell anergy.

Main Methods:

• 17 adult male mite-sensitive asthmatic patients received 0.5-3 mg/day of freeze-dried Dermatophagoides farinae mite extract for 12 weeks.
• Clinical symptoms, peak expiratory flow (PEF), bronchial provocation tests (BPT), peripheral blood eosinophil counts, and Interleukin-5 (IL-5) production were assessed.
• Symptom scores and PEF were used to evaluate clinical improvement.

Main Results:

• 47% of patients (8/17) showed marked or moderate improvement in clinical symptoms and PEF.
• Statistically significant improvement was observed in BPT, particularly the late asthmatic response.
• Peripheral blood eosinophil counts and spontaneous IL-5 production by peripheral mononuclear cells significantly decreased post-OIT.

Conclusions:

• Oral immunotherapy with Dermatophagoides farinae mite extract demonstrates clinical efficacy in allergic asthma.
• The observed improvements suggest a reduction in allergic inflammation and airway hyperresponsiveness.
• These findings indicate that OIT may be a viable strategy for inducing T cell anergy in allergic asthma treatment.